KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRAS(G12C) mutation Meeting Abstract
| Authors: | Spira, A. I.; Riely, G. J.; Gadgeel, S. M.; Heist, R. S.; Ou, S. H. I.; Pacheco, J. M.; Johnson, M. L.; Sabari, J. K.; Leventakos, K.; Yau, E.; Bazhenova, L.; Negrao, M. V.; Pennell, N. A.; Zhang, J.; Velastegui, K.; Christensen, J. G.; Yan, X.; Anderes, K. L.; Chao, R. C.; Janne, P. A. |
| Abstract Title: | KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRAS(G12C) mutation |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680302193 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.9002 |
| Notes: | Meeting Abstract: 9002 -- Meeting also held virtually -- Source: Wos |
